GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuhan Corp (XKRX:000100) » Definitions » Additional Paid-In Capital

Yuhan (XKRX:000100) Additional Paid-In Capital : ₩106,809 Mil(As of Mar. 2024)


View and export this data going back to 1962. Start your Free Trial

What is Yuhan Additional Paid-In Capital?


Yuhan's quarterly additional paid-in capital declined from Sep. 2023 (₩113,946 Mil) to Dec. 2023 (₩113,901 Mil) but then stayed the same from Dec. 2023 (₩113,901 Mil) to Mar. 2024 (₩106,809 Mil).

Yuhan's annual additional paid-in capital increased from Dec. 2021 (₩112,222 Mil) to Dec. 2022 (₩116,065 Mil) but then declined from Dec. 2022 (₩116,065 Mil) to Dec. 2023 (₩113,901 Mil).

Yuhan Additional Paid-In Capital Historical Data

The historical data trend for Yuhan's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yuhan Additional Paid-In Capital Chart

Yuhan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 111,891.78 114,369.00 112,221.93 116,065.11 113,901.09

Yuhan Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 111,516.02 111,679.17 113,945.71 113,901.09 106,809.47

Yuhan Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Yuhan Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Yuhan's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Yuhan (XKRX:000100) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuhan Corp (XKRX:000100) » Definitions » Additional Paid-In Capital
Comparable Companies
XKRX:128940 XKRX:068760 XKRX:009420 XKRX:000250 XKRX:237690 XKRX:195940 XKRX:069620 XKRX:185750 XKRX:006280 XKRX:086450 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
000105:Korea
Address
74, Noryangjin-ro, Dongjak-gu, Seoul, KOR
Website
http://www.yuhan.co.kr
Yuhan Corp is a pharmaceutical company. The core business of the company is classified as primary and specialty care, dietary supplement, household and animal care, and contract manufacturing of active pharmaceutical ingredients. Yuhan offers one-stop custom synthesis services from research and development to commercial production of active pharmaceutical products (APIs) and intermediates for the following disease treatments: antivirals (HCV and HIV), antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds for international markets.

Yuhan (XKRX:000100) Headlines

No Headlines